En español



Quick Links

COVID-19 is an emerging, rapidly evolving situation.

Get the latest information from CDC (coronavirus.gov) | NIH Resources | NIDA Resources

Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT)

The opioid epidemic has reached a critical state, drawing widespread attention and support to address this public health crisis.  For many reasons, the Emergency Department (ED) is a critical venue to initiate opioid use disorder (OUD) interventions.  ED patients have a disproportionately high prevalence of substance use disorders, are at an elevated risk of overdose, and many do not access healthcare elsewhere.  Despite this, OUD interventions are rarely initiated in EDs.  As a complement to the CTN-0069 project, this study will evaluate the feasibility, acceptability, and impact of introducing a clinical protocol for OUD screening, buprenorphine (sublingual or extended-release) treatment initiation, and referral to ongoing OUD medication treatment in ED settings with high need, limited resources, and differing staffing structures.

CTN Protocol ID: 
ClinicalTrials.gov ID: 
Principal Investigator(s)
Ryan McCormack, M.D.
Assistant Professor
New York University School of Medicine
Bellevue Hospital Center
462 First Avenue, OBV A345
New York, NY 10016

John Rotrosen, M.D.
NYU School of Medicine
Department of Psychiatry
One Park Avenue, 8th Floor
New York, NY 10016

Participating Sites:

Get this Publication

    CTN Dissemination Initiative

    CTN Dissemination Initiative Logo

    Incorporates collaboration between clinicians, scientists, and experienced trainers.